Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
6.58
-0.12 (-1.79%)
Aug 1, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '18
Novel Integrated Drug and Drug Delivery Solutions
1.56M
Log In
Log In
Log In
Novel Integrated Drug and Drug Delivery Solutions Growth
14.31%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '18
United States
1.56M
Log In
Log In
Log In
United States Growth
14.31%
Log In
Log In
Log In